UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Catheterization and cardiovascular interventions, 2020-11, Vol.96 (5), p.E508-E515

2020

Volltextzugriff (PDF)

Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial

BMC cardiovascular disorders, 2023-05, Vol.23 (1), p.238-238, Article 238

2023

Volltextzugriff (PDF)

Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo

International Journal of Cardiovascular Imaging, 2009-01, Vol.25 (1), p.13-23

2009

Volltextzugriff (PDF)

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association, 2018-02, Vol.7 (3), p.n/a

2018

Volltextzugriff (PDF)

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012-07, Vol.8 (3), p.336

2012

Volltextzugriff (PDF)

Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy

EuroIntervention, 2009-05, Vol.5 (1), p.157

2009

Volltextzugriff (PDF)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

Catheterization and cardiovascular interventions, 2020-08, Vol.96 (2), p.E110-E118

2020

Volltextzugriff (PDF)

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017-11, Vol.13 (10), p.1168

2017

Volltextzugriff (PDF)

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012-10, Vol.8 (6), p.664

2012

Volltextzugriff (PDF)

Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents

EuroIntervention, 2009-09, Vol.5 (4), p.505

2009

Volltextzugriff (PDF)

Impact of analyzing fewer image frames per segment during offline volumetric radiofrequency-based intravascular ultrasound measurements of target lesions prior to percutaneous coronary interventions

International Journal of Cardiovascular Imaging, 2012-03, Vol.28 (3), p.479-489

2012

Volltextzugriff (PDF)

Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial

Catheterization and cardiovascular interventions, 2015-02, Vol.85 (3), p.E76-E82

2015

Volltextzugriff (PDF)

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Catheterization and cardiovascular interventions, 2015-01, Vol.85 (1), p.74-81

2015

Volltextzugriff (PDF)

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015-06, Vol.11 (2), p.180

2015

Volltextzugriff (PDF)

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-07, Vol.12 (4), p.431

2016

Volltextzugriff (PDF)

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015-03, Vol.10 (11), p.1276

2015

Volltextzugriff (PDF)

Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial

Catheterization and cardiovascular interventions, 2013-09, Vol.82 (3), p.396-405

2013

Volltextzugriff (PDF)

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-04, Vol.11 (13), p.1487

2016

Volltextzugriff (PDF)

Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first- and second-generation drug-eluting stents

Catheterization and cardiovascular interventions, 2012-10, Vol.80 (4), p.524-530

2012

Volltextzugriff (PDF)

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014-11, Vol.10 (7), p.784

2014

Volltextzugriff (PDF)

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014-10, Vol.10 (6), p.664

2014

Volltextzugriff (PDF)

Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy

Arteriosclerosis, thrombosis, and vascular biology, 2000-11, Vol.20 (11), p.2434

2000

Volltextzugriff (PDF)

Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond

Cardiovascular diagnosis and therapy, 2012-12, Vol.2 (4), p.261-263

2012

Volltextzugriff (PDF)

Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy

Journal of lipid research, 2003-08, Vol.44 (8), p.1462-1469

2003

Volltextzugriff (PDF)

Etiology, management, and outcome of the Budd-Chiari syndrome

Annals of internal medicine, 2009-08, Vol.151 (3), p.167

2009

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(27)
Cardiovascular System & Cardiology
(26)
Cardiac & Cardiovascular Systems
(23)
Male
(23)
Middle Aged
(22)
Female
(21)
Aged
(15)
Percutaneous Coronary Intervention
(14)
Drug-Eluting Stents
(13)
Treatment Outcome
(13)
Biological And Medical Sciences
(10)
Coronary Artery Disease
(10)
Medical Sciences
(10)
Coronary Artery Disease - Therapy
(9)
Risk Factors
(9)
Time Factors
(9)
Percutaneous Coronary Intervention - Adverse Effects
(8)
Percutaneous Coronary Intervention - Instrumentation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial

Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry

Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents

Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents

Impact of analyzing fewer image frames per segment during offline volumetric radiofrequency-based intravascular ultrasound measurements of target lesions prior to percutaneous coronary interventions

Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first- and second-generation drug-eluting stents

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy

Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond

Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy

Etiology, management, and outcome of the Budd-Chiari syndrome

Aktive Filter

Suchergebnisse filtern